单细胞转录组学揭示了肺癌患者中预先存在的COVID-19脆弱性因素
Wendao Liu1,2, Wenbo Li1,3, Zhongming Zhao1,2,4
1The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, Texas.
Molecular cancer research : MCR
|December 8, 2023
概括
由于共同的分子通路,癌症患者面临更高的COVID-19风险. 这项研究揭示了肺癌如何通过炎症和免疫抑制加剧COVID-19的严重程度,并确定了潜在的治疗点.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
背景情况:
- 癌症和2019年新冠病毒病 (COVID-19) 是全球重要的健康问题.
- 患有癌症的患者对严重的COVID-19结果的脆弱性增加.
- 这种增加敏感性的分子基础在很大程度上仍然未被阐明.
研究的目的:
- 研究癌症患者COVID-19风险增加背后的分子机制.
- 为了比较COVID-19中的细胞和分子变化,肺癌和正常的肺组织.
主要方法:
- 从COVID-19患者,肺腺癌,小细胞肺癌和健康对照患者的单细胞RNA测序数据的综合分析.
- 细胞群的表征,基因表达特征和细胞间通信网络.
主要成果:
- 确定COVID-19和肺癌之间共享的病理特征.
- 在上皮细胞中观察到TMPRSS2表达的升级,巨细胞介导炎症的增加,T细胞反应的抑制,以及纤维细胞的纤维化风险增加.
- 这些因素可能会导致肺癌患者更严重的COVID-19.
结论:
- 这项研究阐明了潜在的分子机制,导致肺癌患者的COVID-19脆弱性.
- 研究结果表明,癌症患者的先前存在的疾病可能会使COVID-19的严重程度恶化.
- 确定的途径和目标为高风险人群中COVID-19的预防和治疗策略提供了途径.
相关概念视频
lncRNA - Long Non-coding RNAs
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...


